XML 90 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Schedule of Income Taxes (Tables)
12 Months Ended
Dec. 31, 2013
Schedule of Income Taxes:  
Schedule of Components of Income Tax Expense (Benefit)

The components of loss before income taxes and the provision for income taxes for the years ended December 31, 2013, 2012 and 2011 are as follows:

 

Loss before income taxes:

2013

 

2012

 

2011

United States

 

$

(61,730,000)

 

$

(30,399,000)

 

$

(25,483,000)

Foreign

 

(1,350,000)

 

(1,463,000)

 

(1,971,000)

 

 

$

(63,080,000)

 

$

(31,862,000)

 

$

(27,454,000)

 

 

 

 

 

 

 

 

 

 

Income tax benefit

2013

 

2012

 

2011

United States

 

$

 

  $

 

  $

Foreign

 

(410,000)

 

 

 

 

 

 

 

 

 

 

 

$

(410,000)

 

  $

 

  $

 

 

 

 

 

 

 

Schedule of Income before Income Tax, Domestic and Foreign

The significant components of U.S. deferred income tax expense (benefit) for the years ended December 31, 2013, 2012 and 2011 are as follows:

 

 

2013

 

2012

 

2011

Deferred tax (benefit) expense

$

(3,209,000)

 

$

10,661,000 

 

$

17,774,000 

Net operating loss carryforward (generated) expired

(6,536,000)

 

26,924,000 

 

187,597,000 

Valuation allowance increase (decrease)

9,745,000 

 

(37,585,000)

 

(205,371,000)

Provision for Income taxes

$

 

$

 

$

 

 

 

 

 

 

 

 

The significant components of foreign deferred income tax expense (benefit) for the years ended December 31, 2013, 2012 and 2011 are as follows:

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Deferred tax expense (benefit)

$

1,406,000 

 

$

(1,041,000)

 

$

(1,268,000)

Net operating loss carryforward expired (generated)

(15,000)

 

(79,000)

 

496,000 

Valuation allowance (decrease) increase

(1,391,000)

 

1,120,000 

 

772,000 

Provision for Income taxes

$

 

$

 

$

Schedule of Effective Income Tax Rate Reconciliation

The Company’s effective income tax rate differed from the federal statutory rate as follows:

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

U.S. Federal statutory tax rate

 

(35.0%)

 

(35.0%)

 

(35.0%)

Deferred state taxes, net of federal benefit

 

 

(1.3%)

 

(3.3%)

 

(3.1%)

Common stock warrant liability

 

 

20.6% 

 

(5.3%)

 

(4.4%)

Gain on Hypulsion transaction

 

 

(1.8%)

 

0.0% 

 

0.0% 

Other, net

 

 

0.1% 

 

0.1% 

 

0.6% 

Change to uncertain tax positions

 

 

(1.3%)

 

(1.6%)

 

(57.5%)

Foreign tax rate differential

 

 

0.2% 

 

0.5% 

 

0.8% 

Expiring attribute carryforward

 

 

2.2% 

 

0.0% 

 

5.4% 

Adjustments to open deferred tax balance

 

 

(0.3%)

 

(5.8%)

 

(1.7%)

Writeoff of tax attributes due to imposition of Section

 

 

 

 

 

 

 

382 limitation

 

 

1.5% 

 

165.7% 

 

840.9% 

Tax credits

 

 

0.0% 

 

0.0% 

 

(0.3%)

Change in valuation allowance

 

 

14.5% 

 

(115.3%)

 

(745.7%)

 

 

 

(0.6%)

 

0.0% 

 

0.0% 

Schedule of Deferred Tax Assets and Liabilities

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of certain assets and liabilities for financial reporting and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2013 and 2012 are as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S.

 

Foreign

 

Years ended December 31,

 

Years ended December 31,

 

2013

 

2012

 

2013

 

2012

Intangible assets

$

59,000 

 

$

130,000 

 

$

999,000 

 

$

694,000 

Deferred revenue

3,425,000 

 

2,779,000 

 

 

Other reserves and accruals

1,253,000 

 

1,621,000 

 

 

Tax credit carryforwards

 

 

84,000 

 

1,569,000 

Property, plant and equipment

1,450,000 

 

1,541,000 

 

504,000 

 

541,000 

Amortization of stock-based compensation

9,183,000 

 

8,495,000 

 

 

Capitalized research & development expenditures

13,775,000 

 

15,846,000 

 

5,195,000 

 

5,384,000 

Net operating loss carryforwards

9,883,000 

 

3,347,000 

 

3,556,000 

 

3,541,000 

Total deferred tax asset

39,028,000 

 

33,759,000 

 

10,338,000 

 

11,729,000 

Valuation allowance

(26,746,000)

 

(17,001,000)

 

(10,338,000)

 

(11,729,000)

Net deferred tax assets

$

12,282,000 

 

$

16,758,000 

 

$

 

$

Non-employee stock based compensation

(1,556,000)

 

(1,556,000)

 

 

Section 382 recognized built in loss

(10,726,000)

 

(15,202,000)

 

 

 

Net deferred tax liability

$

(12,282,000)

 

$

(16,758,000)

 

$

 

$

Net

$

 

$

 

$

 

$

 

 

 

 

 

 

 

 

Schedule of Valuation Allowance

.  A reconciliation of the current year change in valuation allowance is as follows:

 

 

 

 

 

 

 

 

 

 

Total

 

U.S.

 

Foreign

Increase in valuation allowance for current year increase in net operating losses:

$

6,529,000 

 

$

6,536,000 

 

$

(7,000)

Increase in valuation allowance for current year net increase in deferred tax assets

 

 

 

 

 

other than net operating losses:

3,587,000 

 

3,209,000 

 

378,000 

Decrease in valuation allowance as a result of foreign currency fluctuation

(798,000)

 

 

(798,000)

 

 

 

 

 

 

Decrease in valuation allowance as a result of tax attribute expiration

(1,478,000)

 

 

(1,478,000)

Increase in valuation allowance due to current year change of deferred tax assets

 

 

 

 

 

as the result of uncertain tax positions.

514,000 

 

 

514,000 

Net increase (decrease) in valuation allowance

$

8,354,000 

 

$

9,745,000 

 

$

(1,391,000)

Schedule of Unrecognized Tax Benefits

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

 

 

 

 

 

 

 

 

 

2013

 

2012

 

2011

Unrecognized tax benefits balance at beginning of year

$

1,579,000 

 

$

2,046,000 

 

$

17,893,000 

Reductions for tax positions of prior years

(471,000)

 

(503,000)

 

(15,875,000)

Currency Translation

(75,000)

 

36,000 

 

28,000 

Unrecognized tax benefits balance at end of year

$

1,033,000 

 

$

1,579,000 

 

$

2,046,000